🟢 Oncolytics Biotech is trading 5.8% up today amid a broad biotech sector and market rally

Oncolytics Biotech is trading 5.8% up at $0.82 amid a strong risk-on session in U.S. equities and a broad biotech sector rally.

• The move aligns with a wider market uptrend, as major indices and the XBI biotech ETF are both trading over 2% higher.
• No company-specific news, earnings, or FDA decisions have been reported today, indicating the advance is driven by sector and macro sentiment rather than a fundamental catalyst.